Now Is The Time To Build A Position In Instil Bio Inc (NASDAQ:TIL)

Instil Bio Inc (NASDAQ:TIL)’s traded shares stood at 0.6 million during the last session, with the company’s beta value hitting 2.15. At the close of trading, the stock’s price was $27.5, to imply an increase of 15.50% or $3.69 in intraday trading. The TIL share’s 52-week high remains $92.00, putting it -234.55% down since that peak but still an impressive 65.02% since price per share fell to its 52-week low of $9.62. The company has a valuation of $180.40M, with an average of 0.34 million shares in intraday trading volume over the past 10 days and average of 294.52K shares over the past 3 months.

Analysts have given a consensus recommendation of Hold for Instil Bio Inc (TIL), translating to a mean rating of 1.75. Of 2 analyst(s) looking at the stock, 0 analyst(s) give TIL a Sell rating. 0 of those analysts rate the stock as Overweight while 2 advise Hold as 0 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -2.44.

Instil Bio Inc (NASDAQ:TIL) trade information

After registering a 15.50% upside in the last session, Instil Bio Inc (TIL) has traded red over the past five days. The 5-day price performance for the stock is 24.04%, and -8.03% over 30 days. With these gigs, the year-to-date price performance is 166.99%. Short interest in Instil Bio Inc (NASDAQ:TIL) saw shorts transact 0.81 million shares and set a 1.81 days time to cover.

The extremes give us $2 and $180 for target low and target high price respectively. As such, TIL has been trading -554.55% off suggested target high and 92.73% from its likely low.

TIL Dividends

Instil Bio Inc has its next earnings report out on 2025-May-13. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

Instil Bio Inc (NASDAQ:TIL)’s Major holders

Instil Bio Inc insiders hold 6.51% of total outstanding shares, with institutional holders owning 80.57% of the shares at 86.18% float percentage. In total, 80.57% institutions holds shares in the company, led by CURATIVE VENTURES V LLC. As of 2024-06-30, the company held over 1.9 million shares (or 29.1979% of shares), all amounting to roughly $19.54 million.

The next major institution holding the largest number of shares is VIVO CAPITAL, LLC with 0.62 million shares, or about 9.5994% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $6.42 million.

We also have VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Instil Bio Inc (TIL) shares. Going by data provided on Mar 31, 2025 , VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund holds roughly 102.91 shares. This is just over 1.57% of the total shares, with a market valuation of $2.83 million. Data from the same date shows that the other fund manager holds a little less at 60.76, or 0.93% of the shares, all valued at about 1.67 million.

Marketing Sentinel
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.